SUBSCRIBE
SUBSCRIBE
News   Policy

MedWatch: Update of Safety Review for Vytorin, Zetia, and Zocor

January 9, 2009 | 
1 min read
The FDA has completed its review of the final clinical study report of ENHANCE and issued an update. Read the MedWatch safety summary, including links to the January 2008 FDA Early Communication and the January 2009 Update.
Regulatory
Merck & Co. Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Four miniature figurines of men in casual and formal attire stand around a large stopwatch showing zero, symbolizing time management or competition.
Regulatory
FDA Breakthrough Designations Lead to Priority Reviews, Report Finds
November 20, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Bayer office in Basel, Switzerland
Lung cancer
Bayer Wins Lung Cancer Accelerated Approval for Kinase Inhibitor
November 20, 2025
 · 
1 min read
 · 
Tristan Manalac
FDA commissioner Marty Makary speaking on a Youtube video, wearing a dark suit and a blue tie
FDA
Makary Eyes ‘America-First’ User Fee Structure as Renewal Negotiations Approach
November 19, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Billions More in M&A, Another Bidding War and More FDA Drama
November 19, 2025
 · 
1 min read
 · 
Heather McKenzie